Maryland Launches Nation's Most Comprehensive Opioid Settlement Transparency Dashboard

Maryland has unveiled the nation's most comprehensive public dashboard for tracking opioid settlement funds, creating a new benchmark for transparency in how states manage the billions of dollars flowing from pharmaceutical litigation. The interactive platform, launched May 28 by Lieutenant Governor Aruna Miller and the state's Office of Overdose Response, allows residents to monitor exactly how $747 million in settlement money moves from courtrooms to communities over the next fifteen years.

The dashboard arrives at a critical moment in the nation's response to the opioid crisis. While overdose deaths have declined nationally for three consecutive years, questions about accountability in settlement fund deployment have grown louder. Maryland's approach directly addresses those concerns by making every dollar traceable from receipt through allocation to local governments and ultimately to specific prevention and treatment programs.

From Legal Victory to Public Accountability

Maryland expects to receive more than $747 million through finalized settlements with prescription opioid manufacturers, distributors, and retail pharmacies. As of fiscal year 2025, approximately $245.8 million has already arrived in state coffers, with nearly $170 million either distributed to or available for counties, cities, and towns across Maryland.

The dashboard breaks down these figures in granular detail, showing not just totals but the specific sources of each settlement payment. Users can explore which pharmaceutical companies contributed what amounts, when payments were received, and how the timing of future payments is structured over the settlement's multi-year lifespan.

This level of specificity matters because the opioid litigation represents one of the largest civil settlements in American history, with more than $50 billion flowing to states and local governments nationwide. Yet the mechanisms for ensuring these funds actually reach addiction treatment and prevention programs have varied dramatically by jurisdiction, with some states providing minimal public reporting on how settlement dollars are spent.

What the Dashboard Reveals

The platform's interface allows Maryland residents to explore settlement fund data through multiple lenses. At the state level, users can track total receipts against projected future payments, creating a clear picture of the settlement's long-term financial trajectory. The dashboard also shows how funds are allocated between state agencies and local governments, addressing a tension that has complicated settlement implementation in other states.

For local communities, the dashboard provides visibility into what funds are available in each jurisdiction. This matters because settlement agreements typically require that money flow to the specific communities most affected by the opioid crisis, rather than being concentrated in state capitals. Maryland's approach of making local allocations transparent helps ensure that counties and municipalities with the highest overdose burdens receive proportionate resources.

Critically, the dashboard includes information about how local governments plan to use the funds in their communities. This planning component addresses one of the most significant challenges in settlement implementation: the gap between receiving money and deploying it effectively. By requiring and publishing local expenditure plans, Maryland creates accountability for converting settlement dollars into measurable public health outcomes.

Legislative Foundation for Transparency

The dashboard was created following legislation passed during Maryland's 2025 General Assembly session, reflecting a deliberate policy choice to prioritize transparency in settlement fund management. State leaders emphasized that the platform represents more than a technical achievement—it embodies a commitment to treating pharmaceutical settlement funds as public resources requiring public oversight.

The legislation established clear parameters for how settlement money can be used. Funds must address harms caused by the opioid crisis and cannot replace existing program funding. This prohibition against supplanting existing budgets addresses a concern that has emerged in other states, where settlement money sometimes flows to general revenue rather than expanding addiction services.

The dashboard will be updated annually following review of local expenditure reports, creating an ongoing accountability mechanism rather than a one-time disclosure. This regular update cycle ensures that the platform remains current and that any discrepancies between planned and actual spending become visible to the public.

Context: Maryland's Opioid Response

The dashboard launch comes as Maryland reports significant progress in reducing overdose mortality. The state achieved a 57% reduction in opioid overdose deaths since pandemic peak, reaching a ten-year low of just over 1,000 fatalities in 2025 compared to 2,500 in 2020. This decline significantly outpaces the national average and suggests that Maryland's comprehensive approach—including harm reduction expansion, medication-assisted treatment access, and now transparent settlement fund management—may offer lessons for other states.

The state's Opioid Restitution Fund has provided sustainable financing for these efforts, with $245 million received in the current fiscal year alone. The new dashboard adds a layer of public accountability to this funding stream, allowing residents to see exactly how litigation victories translate into community-level services.

National Implications

Maryland's dashboard arrives as states across the country grapple with similar challenges in managing opioid settlement funds. Michigan launched its own tracking system earlier this year, creating a public reporting dashboard combined with detailed spending guidance. Other states have taken different approaches, with some providing minimal transparency and others, like Indiana, facing criticism for allowing settlement funds to be diverted to unrelated expenses.

The variation in state approaches reflects the decentralized nature of opioid litigation settlements. While the underlying litigation was coordinated nationally, implementation was deliberately left to individual states and local governments. This structure was intended to ensure that communities most affected by the crisis would control how resources are deployed, but it has also created inconsistencies in accountability and effectiveness.

Maryland's dashboard may influence how other states approach settlement transparency. The technical infrastructure for such platforms is not prohibitively complex, and the public benefits of transparency are clear. For communities that have lost thousands of residents to overdose, the ability to track whether pharmaceutical settlement money is actually reaching treatment and prevention programs represents a form of accountability that extends beyond the courtroom.

Looking Forward

As opioid settlement funds continue flowing to states over the coming decade, the question of how that money is spent will only grow more consequential. Maryland's dashboard provides a template for treating these funds as what they are: compensation for profound community harm that must be deployed transparently to prevent future devastation.

The platform also creates opportunities for research and advocacy. Public health researchers can analyze correlations between settlement fund deployment and overdose mortality trends. Community advocates can use dashboard data to press for more resources in underserved areas. And policymakers in other states can examine Maryland's approach as they develop their own accountability mechanisms.

For a state that has seen overdose deaths fall by more than half since the pandemic's darkest days, the dashboard represents both a tool for maintaining progress and a statement about how pharmaceutical litigation settlements should be managed. The message is clear: when companies pay for the damage their products caused, the public has a right to know exactly how that money is used to heal communities and save lives.